Showing results (1271-1280 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|May 7, 2026
Oral bisphosphonates and risk of incident osteoarthritis in individuals with osteoporosis: a target trial emulationMasaki Hatano, Yuya Kimura, Akira Okada, et al.
RMD Open|May 7, 2026
Nerandomilast alleviates myositis-associated interstitial lung disease by modulating the non-Smad signalling pathway and activating the cAMP-PKA-RhoA pathwayXi Cui, Wenjun Li, Hui Chai, et al.
RMD Open|May 7, 2026
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritisZohra Faizy Ahmadzay, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, et al.
RMD Open|May 11, 2026
Ultrasound assessment of vertebral ligaments: development and validation of a landmark-based scanning protocol with potential applicability in spondyloarthritisChiara Rizzo, Luis Coronel, Maribel Miguel-Perez, et al.
RMD Open|May 29, 2025
Definitions of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working GroupAlessandro Tomelleri, Christian Dejaco, Wolfgang A Schmidt, et al.
RMD Open|April 9, 2026
Severe thrombocytopenia in antiphospholipid syndrome: a retrospective study of 432 patientsCarine Schmidt, Matthias Papo, Dov Taïeb, et al.
RMD Open|April 24, 2026
Sustaining remission in rheumatoid arthritis: the role of clinical deep remission and its implications for drug taperingHaihui Li, Mengyan Zhou, Huaqun Zhu, et al.
RMD Open|May 4, 2026
Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articlesAlain Lescoat, Yannick Allanore, Francesco Del Galdo, et al.
RMD Open|May 13, 2026
Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for RheumatologyVeronica Batani, Ilaria Cavazzana, Martina Orlandi, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Pageof 197